▲ SURGE

Rallybio Corporation

+50.1%
RLYBNASDAQHealthcare2026-05-04
14.12
Close
9.41
Prev Close
+50.05%
Change
150.2x
Vol Ratio

Why It Surged

No related news available.

Related News

ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Feder
Gurufocus2026-04-29
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Tipranks2026-03-19
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history
Au.Finance.Yahoo2026-04-26
Eli Lilly’s LY3537031 Renal Study Moves Forward, Shaping Early Pipeline Expectations
Tipranks2026-04-25
Roundtable CEO James Heckman Details NASDAQ Strategy, Long-Term Focus, Capitalization Structure, and Lock-Up
Thestreet2026-04-06

Technical Analysis

No technical analysis available.

View CompanyBack to Surge Stocks
Rallybio Corporation Surged +50.1% on 2026-05-04 — Analysis | Alpha Lenz